Date Filed | Type | Description |
08/11/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
06/12/2023 |
SC 13G
| Artal International S.C.A. reports a 6.6% stake in Selecta Biosciences, Inc. |
06/05/2023 |
4
| Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns:
| Bought 27,775,050 shares
@ $2.6, valued at
$72.2M
|
|
05/12/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
05/11/2023 |
4
| Westend S.A. (10% Owner) has filed a Form 4 on WW INTERNATIONAL, INC.
Txns:
| Sold 14,818,300 shares
@ $7.15, valued at
$106M
|
|
05/02/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Bought 31,557 shares
@ $6.4279, valued at
$202.8k
|
|
03/31/2023 |
SC 13G
| Artal International S.C.A. reports a 6.1% stake in Harpoon Therapeutics, Inc. |
02/28/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC
Txns:
| Bought 100,000 shares
@ $1.7, valued at
$170k
|
|
02/23/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC
Txns:
| Bought 50,000 shares
@ $1.85, valued at
$92.5k
Bought 150,000 shares
@ $1.7933, valued at
$269k
Bought 200,000 shares
@ $1.7538, valued at
$350.8k
|
|
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/13/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/01/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
01/11/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Sold 1,094 shares
@ $9.482, valued at
$10.4k
|
|
01/09/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Bought 48,774 shares
@ $9.3306, valued at
$455.1k
|
|
11/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/07/2022 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Bought 33,971 shares
@ $7.0292, valued at
$238.8k
Bought 66,000 shares
@ $7.8903, valued at
$520.8k
|
|
08/23/2022 |
SC 13G
| Artal International S.C.A. reports a 6.4% stake in Vigil Neuroscience, Inc. |
08/11/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
08/09/2022 |
4
| Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns:
| Bought 2,426,070 shares
@ $2.5, valued at
$6.1M
|
|
08/05/2022 |
SC 13G
| Artal International S.C.A. reports a 6% stake in AlloVir, Inc. |
08/01/2022 |
4
| Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns:
| Bought 16,173,800 shares
@ $2.5, valued at
$40.4M
|
|
06/24/2022 |
SC 13G/A
| Artal International S.C.A. reports a 19.4% stake in Scholar Rock Holding Corporation |
06/24/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/12/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/11/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 8.3% stake in SEER, INC. |
02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 8.2% stake in BELLUS Health Inc. |
02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 5.8% stake in IGM Biosciences, Inc. |
02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 6.4% stake in Cyclerion Therapeutics, Inc. |
02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 4.9% stake in Generation Bio Co. |
02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 7% stake in Scholar Rock Holding Corporation |
|